• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Technology
    • AI
    • History of Otolaryngology
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
    • SUO Corner
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

AMA’s Opt-Out Provision for Sale of Physician Prescribing Data Seen as First Step

by Terry Hartnett • August 1, 2006

  • Tweet
  • Email a link to a friend (Opens in new window) Email
Print-Friendly Version

Nothing in this section shall prohibit the dispensing of prescription medications to a patient or to the patient’s authorized representative; the transmission of prescription information between an authorized prescriber and a licensed pharmacy; the transfer of prescription information between licensed pharmacies; the transfer of prescription records that may occur in the event a pharmacy ownership is changed or transferred; care management educational communications provided to a patient about the patient’s health condition, adherence to a prescribed course of therapy, or other information about the drug being dispensed, treatment options, or clinical trials. Nothing in this section shall prohibit the collection, use, transfer, or sale of patient and prescriber de-identified data by zip code, geographic region, or medical specialty for commercial purposes.

You Might Also Like

  • Drug Marketing: Different Impacts on Different Physicians
  • Report: Physician Prescribing Behavior Changes Following Restrictions on Direct Marketing
  • The Opt-Outs: Otolaryngologists extol the benefits of third-party independence
  • EMR and Advertising: Strange Bedfellows?
Explore This Issue
August 2006

In addition to other appropriate remedies under this chapter, a violation of this section is an unfair or deceptive act or practice within the meaning of RSA 358-A:2. Any right or remedy set forth in RSA 358-A may be used to enforce the provisions of this section.

©2006 The Triological Society

Pages: 1 2 3 4 5 | Single Page

Filed Under: Departments, Everyday Ethics, Health Policy, Practice Management Tagged With: Ethics, healthcare reform, legal, medication, patient education, patient safety, pharmaceuticals, physician safety, policy, privacy, reimbursementIssue: August 2006

You Might Also Like:

  • Drug Marketing: Different Impacts on Different Physicians
  • Report: Physician Prescribing Behavior Changes Following Restrictions on Direct Marketing
  • The Opt-Outs: Otolaryngologists extol the benefits of third-party independence
  • EMR and Advertising: Strange Bedfellows?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Do you think GLP-1s are the next big disruptors in ENT practice?

View Results

Loading ...
  • Polls Archive

Top Articles for Residents

  • The Example We Set: Thoughts on the End of Residency Training
  • Is the SLOR in Otolaryngology Residency Applications Contributing to Rural Disparities?
  • Applications Open for Resident Members of the ENTtoday Editorial Board: Deadline Extended
  • A Resident’s View of AI in Otolaryngology
  • Call for Resident Bowl Questions
  • Popular this Week
  • Most Popular
  • Most Recent
    • How GLP-1s Are Changing Otolaryngology Practice
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • History of the Cochlear Implant
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Empty Nose Syndrome: Physiological, Psychological, or Perhaps a Little of Both?
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?
    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?
    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment
    • Complications for When Physicians Change a Maiden Name
    • Facial Nerve Paralysis: Protecting the Eye and Restoring Function
    • Multi-Institutional Validation of the Interarytenoid Assessment Protocol for Pediatric Laryngeal Cleft
    • DB-OTO Gene Therapy for Inherited Deafness
    • Wearable AR for Nystagmus Examination in Patients with Vertigo: Randomized Crossover Usability Study
    • Increased Prevalence of Hearing Loss and Tinnitus in Patients with Retinal Vein Occlusion

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939